A federal appeals court should reverse a $565 million judgment for patent infringement against Microsoft because the technology behind a browser patent existed at the time of the filing, the software maker’s attorneys told a panel of judges on Thursday.
In a landmark decision that could raise the bar for plaintiffs in federal trademark lawsuits, the U.S. Supreme Court has ruled that the existence of some consumer confusion should not completely bar a fair-use defense.
A U.S. federal judge has denied the appeal of the remaining two sanctions against Samsung Electronics Co. for destroying evidence in a patent dispute with Canadian rival Mosaid Technologies Inc.
A panel of judges at the U.S. Court of Appeals for the Federal Circuit in Washington D.C. is scheduled to hear an appeal this week of a lower court’s decision to order Microsoft Corp. to pay $565 million in damages for infringing a patent with its Internet Explorer web browser.
A U.S. appeals court in Washington, D.C. has rejected Mylan Laboratories' bid to market a generic version of Johnson & Johnson's Duragesic pain-relief skin patch.
In a victory for Samsung Electronics, LG Electronics, Orion Electronic and Hyundai Electronics, South Korea’s Supreme Court has nullified a patent for a plasma display panel (PDP) awarded to Japanese electronics giant Fujitsu in 1995.
The U.S. Supreme Court has refused to hear the University of Rochester’s appeal in its patent dispute with makers of cox-2 inhibitor pain killers, ending a legal battle that has cost the school $10 million.
In the latest round of their decades-long, global battle over trademark rights to the “Bud” beer brand, the European Court of Justice has remanded a lawsuit between Czech brewery Budejovicky Budvar and U.S. beer giant Anheuser-Busch Ltd. back to a Finnish court.
The U.S. Supreme Court has asked the Bush administration for guidance in a case that turns on agrochemical giant Monsanto Co.’s right to bar farmers from replanting patented seeds.
The U.S. Court of Appeals for the Federal Circuit is preparing to get tougher on rule violations, hinting that even inadvertent violations of court rules may result in sanctions in the future.
In a decision with wide implications for interpretations of the Digital Millennium Copyright Act, a federal appeals court has vacated an injunction that barred Static Control Components from making or selling computer chips that match remanufactured toner cartridges to Lexmark International printers.
A California appeals court has upheld more than $500 million in damages against biotech company Genentech in a dispute over royalties on human insulin and human growth hormone developed in part by the City of Hope National Medical Center.
The U.S. Supreme Court has refused to take on the music industry’s appeal of a lower court’s finding that circumscribed the use of the Digital Millennium Copyright Act of 1998 to obtain subpoenas for the identities of suspected music pirates from internet service providers.
Major entertainment companies have asked the U.S. Supreme Court to overturn a lower-court ruling that shields creators of internet file-sharing software from copyright infringement liability.
A district-court jury was improperly instructed before it found that eBay had infringed on two patents held by MercExchange, eBay’s attorneys argued before a three-judge panel of the U.S. Court of Appeals for the Federal Circuit on Tuesday.
The U.S. Supreme Court, which rarely takes on patent cases, has sought the U.S. Solicitor General’s opinion on whether it should review an appeals court’s 2003 decision in a case over research exemptions to patent infringement liability.
A U.S. appeals court has ruled that U.K.-Swedish drug maker AstraZeneca can't prevent U.S.-based Mutual Pharmaceutical Co. from selling a generic form of hypertension drug Plendil.
The U.S. Patent and Trademark Office has preliminarily rejected a patent for Microsoft’s “FAT” system for recognizing computer files, a decision that prompted a vow of a quick appeal by the software maker.
Online auction company eBay Inc. will have a stab at reversing a $29.5 million judgment when it returns to federal court Tuesday to appeal a patent-infringement in favor of rival MercExchange LLC.
Pfizer Inc. will file an official appeal Tuesday against a decision by China's State Intellectual Property Office to overturn the U.S. drug maker’s patent for erectile-dysfunction drug Viagra, the Wall Street Journal’s Asian edition reported.